Pure Global

Coagulation multiple quality control product - NMPA Registration 苏械注准20232400867

Access comprehensive regulatory information for Coagulation multiple quality control product in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 苏械注准20232400867 and owned by Ali Biotech Taizhou Co., Ltd.. The device was approved on June 19, 2023.

This page provides complete registration details including registrant information, province location (Jiangsu), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.

Free Database
Powered by Pure Global AI
NMPA Official Data
Class II
苏械注准20232400867
Coagulation multiple quality control product
凝血多项质控品
NMPA Registration Number: 苏械注准20232400867
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Use
English

It is used for quality control during prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen (FIB), and antithrombin III (AT III) detection.

中文

用于凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)、抗凝血酶III(AT III)检测时的质量控制。

Device Classification
Device Class
Class II
Model Specifications
See annex
见附件
Approval Department
Jiangsu Provincial Drug Administration
江苏省药品监督管理局
Registration Information
Registration Number
苏械注准20232400867
Approval Date
June 19, 2023
Expiry Date
June 18, 2028
Registrant
Name
Ali Biotech Taizhou Co., Ltd.
阿里生物技术泰州有限公司
Province/Region
Jiangsu
江苏
Address
Taizhou National Pharmaceutical High-tech Industrial Park, west of Taizhou Medical City, west of Tai Road, east of Building 0007, G61, East of Lujia Road, east of the first to fourth floors
泰州国家医药高新技术产业园中国医药城口泰路西侧、陆家路东侧0007幢G61号一至四层东侧
Production Facility
Production Address
泰州中国医药城口泰路西侧、陆家路东侧0007幢61号一至四层东侧
Structure and Composition
English

This product is a lyophilized product, composed of sodium citrate anticoagulant plasma (bovine, pig), buffer stabilizer; Level 1 is a normal value control and level 2 is an abnormal value control product. Level 1 target range: prothrombin time (PT): 8~14s, activated partial thromboplastin time (APTT): 21~35s, thrombin time (TT): 10~20s, fibrinogen (FIB): 2~4g/L, antithrombin III (AT III): 80~120% Level 2 Target range: prothrombin time (PT): 18~48s, activated partial thromboplastin time (APTT): 45~75s, Thrombin time (TT): 21~40s, fibrinogen (FIB): 0.7~1.9g/L, antithrombin III(AT III): 30~50%

中文

本产品为冻干品,由枸橼酸钠抗凝血浆(牛、猪)、缓冲稳定剂组成;水平1为正常值质控品,水平2为异常值质控品。水平1靶值范围:凝血酶原时间(PT):8~14s、活化部分凝血活酶时间(APTT):21~35s、凝血酶时间(TT):10~20s、纤维蛋白原(FIB):2~4g/L、抗凝血酶III(AT III):80~120%水平2靶值范围:凝血酶原时间(PT):18~48s、活化部分凝血活酶时间(APTT):45~75s、凝血酶时间(TT):21~40s、纤维蛋白原(FIB):0.7~1.9g/L、抗凝血酶III(AT III):30~50%

Storage Conditions and Expiration
English

1. The quality control products are not opened and stored in the dark at 2 °C ~ 8 °C, and the validity period is 24 months; After reconstitution, store at 2 °C ~ 8 °C in the dark, the validity period is 6 hours. 2. Please refer to the product label for the production date and expiration date.

中文

1.质控品未拆封在2℃~8℃避光保存,有效期为24个月;复溶后在2℃~8℃避光保存,有效期为6小时。2.生产日期、失效日期详见产品标签。

Additional Information
Appendix
产品技术要求、说明书